Dose escalation & switching of biologics in Ulcerative colitis: a systematic literature review in real world evidence.

CONCLUSIONS: Dose escalation and treatment switching of biologics may be considered as indicators of suboptimal therapy suggesting a lack of long-term remission and response under current therapies. PMID: 31192706 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research